Inside (the Beltway) Scoop

By: Ellen Kuo
Thursday, October 29, 2026

White House Announces New Science Investment Initiative

The Trump Administration’s “Science: A New Golden Age” initiative aims to strengthen American scientific leadership, accelerate discovery, and increase the practical benefits of research. Led by the White House Office of Science and Technology Policy (OSTP), under Director Michael Kratsios, the initiative is intended to modernize the nation’s research enterprise through artificial intelligence, advanced computing, new research institutions, and partnerships among federal agencies, universities, industry, and philanthropy. The administration held its Science: A New Golden Age Summit on October 8, 2026, announcing more than $6 billion in investments and commitments across these sectors. The initiative emphasizes technological leadership, scientific innovation, and what the administration describes as a renewed focus on merit in research.

A central component is the Genesis Mission, a government-wide effort to use AI and advanced computing to accelerate scientific discovery. At the summit, major announcements included a $1.8 billion virtual biology initiative involving the National Institutes of Health (NIH), Department of Energy (DOE), and Biohub to develop AI models of cells and biological systems. The National Science Foundation (NSF) and DOE also announced more than $100 million for scientific instrumentation and autonomous laboratories, while industry partners committed $2.4 billion in computing resources, AI models, and related tools for researchers. Other initiatives include new research competitions, early-career scientist training, and experimental research institutions known as X-Labs. Together, these efforts seek to accelerate advances in fields such as biomedical research, quantum computing, energy, and materials science. Additionally, a new coalition wrote a support letter to appropriators about the Genesis Mission, stating America is positioned to lead with partner companies.

For the biomedical research community, the initiative presents both opportunities and questions. Expanded AI infrastructure, virtual biology, and support for early-career investigators could help researchers develop new treatments and accelerate scientific breakthroughs. NIH reported that 1,648 early-stage investigators received R01-equivalent extramural grants in fiscal year 2026, a record number, and announced a new initiative to recruit 100 early-career principal investigators into its intramural research program. However, the initiative’s long-term impact will depend on sustained funding, implementation, access to computing and research infrastructure, and the extent to which investments complement fundamental, investigator-initiated research. For research advocacy organizations, a key consideration is whether these new priorities will strengthen the broader biomedical research enterprise and maintain a robust pipeline of scientific talent.